Literature DB >> 17687114

Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease.

Yanqiu Deng1, Bin Li, Fei Liu, Khalid Iqbal, Inge Grundke-Iqbal, Roland Brandt, Cheng-Xin Gong.   

Abstract

The medium subunit of neurofilament (NF-M) is extensively modified by phosphate and O-linked beta-N-acetylglucosamine (O-GlcNAc). Phosphorylation of NF-M plays a critical role in regulating its translocation, filament formation, and function. However, the regulation of NF-M phosphorylation and the role of NF-M O-GlcNAcylation (a modification by which GlcNAc is attached to the serine/threonine residues of a protein via an O-linked glycosidic bond) are largely unknown. Here, we demonstrate that O-GlcNAcylation and phosphorylation of NF-M regulate each other reciprocally in cultured neuroblastoma cells and in metabolically active rat brain slices. In animal models of fasting rats, which mimicked the decreased glucose uptake/metabolism observed in brains of individuals with Alzheimer disease (AD), we found a decrease in O-GlcNAcylation and increase in phosphorylation of NF-M. We also observed decreased O-GlcNAcylation and an increased phosphorylation of NF-M in AD brain. These results suggest that O-GlcNAcylation and phosphorylation of NF-M are regulated reciprocally and that the hyperphosphorylation and accumulation of NF-M in AD brain might be caused by impaired brain glucose uptake/metabolism via down-regulation of NF-M O-GlcNAcylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687114      PMCID: PMC2262915          DOI: 10.1096/fj.07-8309com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

1.  Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting.

Authors:  Xu Li; Fen Lu; Jian-Zhi Wang; Cheng-Xin Gong
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

Review 2.  Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation.

Authors:  Cheng-Xin Gong; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Alzheimers Dis       Date:  2006-03       Impact factor: 4.472

3.  NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth.

Authors:  Michael L Garcia; Christian S Lobsiger; Sameer B Shah; Tom J Deerinck; John Crum; Darren Young; Christopher M Ward; Thomas O Crawford; Takahiro Gotow; Yasuo Uchiyama; Mark H Ellisman; Nigel A Calcutt; Don W Cleveland
Journal:  J Cell Biol       Date:  2003-12-08       Impact factor: 10.539

4.  O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS).

Authors:  Nina Lüdemann; Albrecht Clement; Volkmar H Hans; Julia Leschik; Christian Behl; Roland Brandt
Journal:  J Biol Chem       Date:  2005-07-08       Impact factor: 5.157

5.  Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices.

Authors:  Cheng-Xin Gong; Jian-Zhi Wang; Khalid Iqbal; Inge Grundke-Iqbal
Journal:  Neurosci Lett       Date:  2003-04-10       Impact factor: 3.046

6.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.

Authors:  Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

Review 7.  Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications.

Authors:  Siegfried Hoyer
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

Review 8.  Cyclin-dependent kinase 5 in neurofilament function and regulation.

Authors:  Sashi Kesavapany; Bing-Sheng Li; Harish C Pant
Journal:  Neurosignals       Date:  2003 Sep-Oct

Review 9.  Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription.

Authors:  Kazuo Kamemura; Gerald W Hart
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2003

10.  Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry.

Authors:  Sarah Trimpin; April E Mixon; Martha D Stapels; Moo-Young Kim; Peter S Spencer; Max L Deinzer
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

View more
  34 in total

Review 1.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 4.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 5.  The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways.

Authors:  Quira Zeidan; Gerald W Hart
Journal:  J Cell Sci       Date:  2010-01-01       Impact factor: 5.285

Review 6.  Neurofilaments at a glance.

Authors:  Aidong Yuan; Mala V Rao; Ralph A Nixon
Journal:  J Cell Sci       Date:  2012-07-15       Impact factor: 5.285

Review 7.  Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

Review 8.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors:  C-X Gong; K Iqbal
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 9.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

10.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.